Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.68 |
| ▸ | ERCC5 | P28715 | 8/20 | 0.67 |
| ▸ | FEN1 | P39748 | 8/20 | 0.67 |
| ▸ | HAO1 | Q9UJM8 | 7/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.49 |
| ▸ | RXRB | P28702 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13675346 | 0.82 | BCL2 (0.71) | BCL2PTGS2RXRARXRBSMN1; SMN2 | |
| SCHEMBL12894973 | 0.82 | BCL2 (1.00) | BCL2PTGS2RXRARXRB | |
| SCHEMBL6943650 | 0.81 | ERCC5 (1.00) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL17740358 | 0.79 | BCL2 (0.71) | BCL2PTGS2PTPN1RXRARXRB | |
| SCHEMBL13099462 | 0.79 | BCL2 (0.76) | BCL2PTGS2RXRARXRBSMN1; SMN2 | |
| SCHEMBL6640696 | 0.77 | BCL2 (0.73) | BCL2PTGS2RXRARXRBSMN1; SMN2 | |
| SCHEMBL13818514 | 0.75 | BCL2 (0.71) | BCL2PTGS2RXRARXRBSMN1; SMN2 | |
| SCHEMBL19149187 | 0.75 | BCL2 (0.69) | BCL2PTGS2RXRARXRBMAPT | |
| SCHEMBL13060851 | 0.75 | BCL2 (0.69) | BCL2PTGS2RXRARXRBMAPT | |
| SCHEMBL3037130 | 0.74 | BCL2 (0.67) | BCL2PTGS2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380249-B1 | HIV integrase inhibitors | MERCK & CO., INC. | 2002-04-30 | — | — | US | claimed |
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | disclosed |
| US-6380249-B1 | HIV integrase inhibitors | MERCK & CO., INC. | 2002-04-30 | — | — | US | disclosed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | disclosed |